PA
HZNP

Parallel Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Parallel Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-454
Closed -$52.5K – 3536
2023
Q3 		$52.5K Sell
454
-3
-0.7% -$322 ﹤0.01% 1372
2023
Q2 		$47K Hold
457
– – ﹤0.01% 1429
2023
Q1 		$49.9K Hold
457
– – ﹤0.01% 1369
2022
Q4 		$52K Sell
457
-4
-0.9% -$332 ﹤0.01% 1266
2022
Q3 		$29K Buy
461
+167
+57% +$11.7K ﹤0.01% 1516
2022
Q2 		$23K Sell
294
-114
-28% -$10.8K ﹤0.01% 1616
2022
Q1 		$43K Buy
408
+162
+66% +$15.8K ﹤0.01% 1361
2021
Q4 		$27K Sell
246
-83
-25% -$9.05K ﹤0.01% 1644
2021
Q3 		$36K Buy
329
+75
+30% +$7.79K ﹤0.01% 1445
2021
Q2 		$24K Buy
254
+26
+11% +$2.39K ﹤0.01% 1599
2021
Q1 		$21K Buy
228
+111
+95% +$9.37K ﹤0.01% 1572
2020
Q4 		$9K Buy
117
+20
+21% +$1.49K ﹤0.01% 1856
2020
Q3 		$8K Buy
97
+40
+70% +$2.75K ﹤0.01% 1870
2020
Q2 		$3K Sell
57
-5
-8% -$214 ﹤0.01% 2150
2020
Q1 		$1K Buy
62
+5
+9% +$169 ﹤0.01% 2361
2019
Q4 		$2K Sell
57
-1,048
-95% -$32.1K ﹤0.01% 2274
2019
Q3 		$30K Buy
1,105
+48
+5% +$1.24K ﹤0.01% 1191
2019
Q2 		$25K Hold
1,057
– – ﹤0.01% 1192
2019
Q1 		$28K Hold
1,057
– – ﹤0.01% 1089
2018
Q4 		$20K Buy
+1,057
New +$20.7K ﹤0.01% 1057

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Parallel Advisors's HZNP Position: Q4 2023 in Review

Parallel Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 454 shares — an estimated $52.5K sold.

Parallel Advisors first reported a position in HZNP in Q4 2018 and held it in 20 quarters. The position peaked at $52.5K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Parallel Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Parallel Advisors sold 454 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $52.5K.
  • Parallel Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 20 quarters.
  • Parallel Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $52.5K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.